I report on the Swiss pharmaceutical industry and healthcare topics such as access to medicine, biomedical innovation, and the impact of diseases like cancer.
I grew up just outside San Francisco and studied international affairs with a focus on development economics and healthcare policy. Prior to joining SWI swissinfo.ch in 2018, I was a freelance journalist and a researcher on business and human rights.
Rare diseases take centre stage at global health summit
This content was published on
Rare diseases have been recognised as a global health priority for the first time. How could this impact access to life-saving treatment?
Novartis bets on ageing as next frontier in drug development
This content was published on
Swiss pharma giant Novartis is diving into research on ageing to tap the growing market for drugs that help keep older adults healthy.
Despite Trump’s bold claims, medicine prices in Europe won’t rise anytime soon
This content was published on
US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong pushback.
Chinese biotechs eye Swiss collaboration as relations with US sour
This content was published on
With growing uncertainty in the US, Chinese companies are swooping in to present themselves as stable, open partners to the Swiss biotech sector.
The Basel researcher whose work triggered a longevity revolution
This content was published on
Basel-based scientist Michael Hall's discovery of the gene Target of Rapamycin has fuelled one of the fastest growing trends – longevity.
What triggers a SLAPP lawsuit in Switzerland? Gold does
This content was published on
Swiss NGO Swissaid is facing off against Switzerland’s largest refinery, Valcambi, in court this week. The case is considered a SLAPP.
This content was published on
People have come to Switzerland for centuries in search of the fountain of youth. How did the country become a magnet for longevity seekers?
Longevity clinics: modern-day snake oil or the key to healthy ageing?
This content was published on
Scientists have yet to find the elixir of life but this hasn't stopped longevity clinics from selling treatments, pills and gadgets that claim to slow ageing.
This content was published on
Looming US pharma tariffs could challenge the status quo in pharmaceutical hubs like Switzerland as investment shifts to the US.
This content was published on
Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill their promise?
Why Switzerland pays more for cancer care than Sweden
This content was published on
More money is spent on cancer in Switzerland per capita than any other country in Europe, but this doesn’t translate to higher survival rates.
Explainer: Why US health funding cuts are rattling Swiss science
This content was published on
The Trump administration has upended funding by the National Institutes of Health. What does it mean for biomedical research in Switzerland?
Swiss regulator and media clash over weight-loss drugs
This content was published on
Swissmedic has taken legal action against media for alleged unauthorised advertising of weight-loss drugs. Swiss media say this is censorship.
What lies ahead for Switzerland: an economic outlook for 2025
This content was published on
Solid growth prospects, the search for a more efficient food industry, uncertainty for the pharma sector: a look at what the upcoming year has in store for the Swiss economy.
Corporate efforts to expand access to medicine stumble
This content was published on
Swiss firm Novartis tops the Access to Medicine Index for the first time. But the pharma industry still lags in making their medicine available to the poorest.
Trump presidency to test public trust in Big Pharma
This content was published on
A second Trump presidency risks eroding public trust in the pharmaceutical industry if science, trade and public health are sidelined.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
